James Gilligan

James Gilligan

Company: Tryp Therapeutics

Job title: President & Chief Executive Officer

Seminars:

Real-Time EEG in Psilocybin Rodent & IV Infused Psilocin Clinical Studies: Does This Provide a Tool to Optimize Precision of Psychedelic Dosing? 10:30 am

Demonstrating changes in EEG patterns when entering the psychedelic state Correlating EEG pattern changes with changes in brain entropy Leveraging EEG to study the plasticity-enhancing effects of psilocybin and its active metabolite psilocin Exploring strategies to correlate rat EEG data with initial clinical EEG results in order to optimize longer-term psychedelic clinical efficacyRead more

day: EEG Focus Day

A Hanson Wade Group Company

© Copyright 2025 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.